Publiziert in: Marktpuls, Unternehmen
Frei

Invitation to Roche's 9 Months Sales 2018 Audio Webcast and Conference Call Montag, 17. September 2018 - 10:01

130960.jpg

Roche will publish its Sales Results for the 3rd Quarter of 2018 prior to the opening of the Swiss Stock Exchange on Wednesday, October 17th, 2018.


07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release
 will be e-mailed and posted on the Roche IR website 
http://download.roche.com/infodesk/3q15/img/icon_link_inline.gifclick here
Presentation slides will be posted on the Roche IR website http://download.roche.com/infodesk/3q15/img/icon_link_inline.gifclick here

We would like to invite all interested parties to dial in as outlined below:

14:00 - 15:15 CEST / 13:00 - 14:15 BST
08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT

Audio webcast and conference call
 will start with presentations by senior management followed by a Q&A session (live access to the speakers).

Presenters:

  • Severin Schwan, CEO Roche Group
  • Daniel O'Day, CEO Roche Pharmaceuticals
  • Michael Heuer, CEO Roche Diagnostics
  • Alan Hippe, Chief Financial and IT Officer

To expedite the registration process on the day of the conference call, you may pre-register for the event > click here

Alternatively you may dial in to the conference 10-15 min prior to the scheduled start using the following numbers:

+41 (0) 58 310 5000
 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)

A live audio webcast can be accessed via 
> ir.roche.com
A replay of the webcast will be available via > ir.roche.com.

Best regards,

Karl Mahler
Head of Investor Relations

Roche Investor Relations

 

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: 
karl.mahler@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: 
sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: 
bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: 
birgit.masjost@roche.com

Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com

 

 

 

Investor Relations North America

 

Loren Kalm
Phone: +1 650 225 3217
e-mail: 
kalm.loren@gene.com

 

 




All rights reserved ©2018 F. Hoffmann-La Roche Ltd.